NAT10/CEBPB/vimentin signalling axis promotes adenoid cystic carcinoma malignant phenotypes in vitro.

Min FuQian GaoMian XiaoXin-Yi SunSheng-Lin LiXi-Yuan Ge

Published in: Oral diseases (2024)

Our study reveals the critical role of the newly identified NAT10/CEBPB/vimentin axis in SACC malignant progression, and the findings may be applied to improve treatment for SACC.

Keyphrases

replacement therapy
smoking cessation